Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

ACTIVE NOT RECRUITING NA

Effectiveness of a Multi-Level Smoking Cessation Program for High-Risk Women in Rural Communities

NCT04340531 · View on ClinicalTrials.gov ↗

Study Summary

This phase IV trial examines the effectiveness of a multi-level smoking cessation program for high-risk women in rural communities. Cigarette smoking is a major risk factor for cervical cancer in women. Rural primary care practices and providers often lack the electronic health record support to pre-identify smokers for services, as well as lack the necessary counseling training and access to comprehensive cessation programs. Implementing evidence-based smoking cessation programs in rural Appalachia may decrease the rates of cigarette smoking and as a result decrease the rates of cervical cancer.

Conditions Studied

Interventions

  • OTHER Survey Administration
  • OTHER Best Practice
  • OTHER Tobacco Cessation Counseling
  • OTHER Training

Study Locations (4)

Kentucky

  • University of Kentucky/Markey Cancer Center — Lexington

Ohio

  • Ohio State University Comprehensive Cancer Center — Columbus

Virginia

  • University of Virginia — Charlottesville

West Virginia

  • West Virginia University — Morgantown

Trial Details

FieldValue
Enrollment Target 810 participants
Start Date 2021-01-30
Est. Completion 2026-05-31
Phase NA

Interested in This Trial?

Always speak with your doctor before enrolling in a clinical trial.

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04340531

The ClinicalTrials.gov registry entry for NCT04340531 describes a study currently listed as active not recruiting. It is categorized as NA, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 810 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University Comprehensive Cancer Center, which has 291 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.

The record links to 1 condition, with Tobacco-Related Carcinoma appearing as the primary indexed condition, and to 4 interventions — of which Survey Administration is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.

Geographic footprint matters for practical reasons: NCT04340531 reports 4 study locations spanning 4 distinct geographic areas — top geographies include Kentucky, Ohio, Virginia. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.

Frequently Asked Questions

What is clinical trial NCT04340531 about?

NCT04340531 is a clinical study titled "Effectiveness of a Multi-Level Smoking Cessation Program for High-Risk Women in Rural Communities". This phase IV trial examines the effectiveness of a multi-level smoking cessation program for high-risk women in rural communities. Cigarette smoking is a major risk factor for cervical cancer in women. Rural primary care practices and providers often lack the electronic health record support to pre...

What is the current status of trial NCT04340531?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 810 participants. The study started on 2021-01-30. Estimated completion is 2026-05-31.

What conditions does trial NCT04340531 study?

This clinical trial studies the following conditions: Tobacco-Related Carcinoma. These conditions were identified from the trial registry and reflect the primary focus areas of the research.

What interventions are being tested in trial NCT04340531?

The interventions under investigation include: Survey Administration (OTHER), Best Practice (OTHER), Tobacco Cessation Counseling (OTHER), Training (OTHER). Each intervention is being evaluated for safety and efficacy as part of this clinical study.

Who is sponsoring clinical trial NCT04340531?

This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 291 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.

Where is trial NCT04340531 being conducted?

This trial has 4 study locations across Kentucky, Ohio, Virginia, West Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Related

Data sourced from official U.S. government datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial